[HTML][HTML] Identifying metabolic alterations in newly diagnosed small cell lung cancer patients
S Pedersen, JB Hansen, RG Maltesen, WM Szejniuk… - Metabolism Open, 2021 - Elsevier
Background Small cell lung cancer (SCLC) is a malignant disease with poor prognosis. At
the time of diagnosis most patients are already in a metastatic stage. Current diagnosis is …
the time of diagnosis most patients are already in a metastatic stage. Current diagnosis is …
Integrated omics and gene expression analysis identifies the loss of metabolite–Metabolite correlations in small cell lung cancer
Background and objective Small cell lung cancer (SCLC) is the most aggressive type of lung
carcinoma with high metastatic potential and chemoresistance upon relapse. Cancer cells …
carcinoma with high metastatic potential and chemoresistance upon relapse. Cancer cells …
Untargeted metabolomics and lipidomics identified four subtypes of small cell lung cancer
C Zhang, X Shang, H Wang - Metabolomics, 2022 - Springer
Introduction Small cell lung cancer (SCLC) is a heterogeneous malignancy with dismal
prognosis. However, few studies have conducted on the metabolic heterogeneity in SCLC …
prognosis. However, few studies have conducted on the metabolic heterogeneity in SCLC …
Construction of a diagnostic model for small cell lung cancer combining metabolomics and integrated machine learning
X Shang, C Zhang, R Kong, C Zhao, H Wang - The Oncologist, 2024 - academic.oup.com
Background To date, no study has systematically explored the potential role of serum
metabolites and lipids in the diagnosis of small cell lung cancer (SCLC). Therefore, we …
metabolites and lipids in the diagnosis of small cell lung cancer (SCLC). Therefore, we …
Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer
J Du, S Yang, X Lin, L Bu, Y Nan, S Huo, W Shang - Diagnostic Pathology, 2010 - Springer
Background The purpose of this study is to discover potential biomarkers in serum for the
detection of small cell lung cancer (SCLC). Methods 74 serum samples including 30 from …
detection of small cell lung cancer (SCLC). Methods 74 serum samples including 30 from …
[HTML][HTML] Landscape and clinical impact of metabolic alterations in non-squamous non-small cell lung cancer
AVI Foureau, W Sha, DM Foureau… - Translational Lung …, 2022 - ncbi.nlm.nih.gov
Background Metabolomics studies to date have described widespread metabolic
reprogramming events during the development of non-squamous non-small cell lung cancer …
reprogramming events during the development of non-squamous non-small cell lung cancer …
Proteomic Profiling of Small-Cell Lung Cancer: A Systematic Review
AM Elshoeibi, B Elsayed, MZ Kaleem, MR Elhadary… - Cancers, 2023 - mdpi.com
Simple Summary Our study centers on refining the diagnosis of small-cell lung cancer
(SCLC), a unique subtype with distinct therapeutic implications compared to other lung …
(SCLC), a unique subtype with distinct therapeutic implications compared to other lung …
Emerging biomarkers and the changing landscape of small cell lung cancer
A Keogh, S Finn, T Radonic - Cancers, 2022 - mdpi.com
Simple Summary Small cell lung cancer (SCLC) is an aggressive cancer representing 15%
of all lung cancers. Unlike other types of lung cancer, treatments for SCLC have changed …
of all lung cancers. Unlike other types of lung cancer, treatments for SCLC have changed …
[HTML][HTML] Are there any theranostic biomarkers in small cell lung carcinoma?
Small cell lung cancer (SCLC), an aggressive lung tumour with a poor prognosis, has a high
load of somatic mutations, mainly induced by tobacco carcinogens given the strong …
load of somatic mutations, mainly induced by tobacco carcinogens given the strong …
High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage …
YJ Lee, A Cho, BC Cho, M Yun, SK Kim, J Chang… - Clinical cancer …, 2009 - AACR
Purpose: We investigated the prognostic effect of incorporating metabolic assessment by
18F-fluoro-2-deoxyglucose uptake on positron emission tomography/computed tomography …
18F-fluoro-2-deoxyglucose uptake on positron emission tomography/computed tomography …